Company Profile
Predictive Oncology Stock Price, News & Analysis
- Ticker:
- POAI
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
5.95 USD
Close
Last updated: December 11, 2025 at 00:00
—
Market cap
Why the stock is moving
POAI is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Predictive Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Predictive Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock.
Business Model Characteristics
Predictive Oncology follows a pipeline-and-commercial model where investors track trial execution, launch cadence, and the pace at which oncology data can be turned into durable product value.
Position Within the Biotechnology Landscape
Compared with larger diversified peers, Predictive Oncology sits in a high-catalyst corner of the biotech landscape, where oncology updates can reprice the stock quickly.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 02
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 03
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Predictive Oncology (POAI)?
Predictive Oncology (POAI) most recently closed at 5.95 USD.
What does Predictive Oncology do?
Predictive Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
On which exchange is POAI stock listed?
Predictive Oncology (POAI) is associated with NASDAQ, United States, Biotechnology.
What is Predictive?
Predictive Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Which conditions is Predictive Oncology targeting with Predictive?
Predictive Oncology is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
What is Oncology?
Predictive Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.